Cargando…

Clinical and imaging characteristics of orbital metastatic lesions among Egyptian patients

PURPOSE: The aim of the study was to review the demographic, clinical, and imaging features of Egyptian patients with orbital metastases. METHODS: The study was a retrospective study of patients with orbital metastatic lesions over the last 15 years. RESULTS: The study included 37 patients. Male pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Eldesouky, Mohammed A, Elbakary, Molham A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574802/
https://www.ncbi.nlm.nih.gov/pubmed/26392748
http://dx.doi.org/10.2147/OPTH.S87788
_version_ 1782390678373793792
author Eldesouky, Mohammed A
Elbakary, Molham A
author_facet Eldesouky, Mohammed A
Elbakary, Molham A
author_sort Eldesouky, Mohammed A
collection PubMed
description PURPOSE: The aim of the study was to review the demographic, clinical, and imaging features of Egyptian patients with orbital metastases. METHODS: The study was a retrospective study of patients with orbital metastatic lesions over the last 15 years. RESULTS: The study included 37 patients. Male patients represented 54.1%. The primary tumor was breast carcinoma in 21.6% of patients, with hepatocellular carcinoma (HCC) in 16.2% and cutaneous malignant melanoma in 13.5% of patients. Bronchogenic carcinoma, prostatic carcinoma, and thyroid adenocarcinoma was the primary tumor in 8.1% of cases each. The most common primary tumor in children was neuroblastoma (42.9% of pediatric patients). In 24.3% of patients, there was no history of cancer, and the orbital metastatic lesion was the first presentation of the disease. Proptosis and/or globe displacement was the presenting feature in 78.4%, followed by diplopia and limited ocular movements in 35.1%, inflammatory manifestations in 10.8%, and ptosis in 5.4%. In 54.1% the lesion involved the right orbit and in 5.4% bilateral involvement was found. Orbital imaging showed infiltrative lesion in 62.2%, mass lesion in 21.6%, isolated muscle thickening in 10.8%, and bone metastasis in 5.4%. All cases of HCC showed osteoclastic changes, and all cases of prostatic carcinoma were osteoblastic lesions. CONCLUSION: Orbital metastasis from HCC represented a higher incidence when compared to previous studies, probably due to the increased incidence of HCC found in the Egyptian population. Orbital metastasis can display a variety of clinical and imaging features, and a high index of suspicion is required, as 24.3% showed negative history of cancer.
format Online
Article
Text
id pubmed-4574802
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-45748022015-09-21 Clinical and imaging characteristics of orbital metastatic lesions among Egyptian patients Eldesouky, Mohammed A Elbakary, Molham A Clin Ophthalmol Original Research PURPOSE: The aim of the study was to review the demographic, clinical, and imaging features of Egyptian patients with orbital metastases. METHODS: The study was a retrospective study of patients with orbital metastatic lesions over the last 15 years. RESULTS: The study included 37 patients. Male patients represented 54.1%. The primary tumor was breast carcinoma in 21.6% of patients, with hepatocellular carcinoma (HCC) in 16.2% and cutaneous malignant melanoma in 13.5% of patients. Bronchogenic carcinoma, prostatic carcinoma, and thyroid adenocarcinoma was the primary tumor in 8.1% of cases each. The most common primary tumor in children was neuroblastoma (42.9% of pediatric patients). In 24.3% of patients, there was no history of cancer, and the orbital metastatic lesion was the first presentation of the disease. Proptosis and/or globe displacement was the presenting feature in 78.4%, followed by diplopia and limited ocular movements in 35.1%, inflammatory manifestations in 10.8%, and ptosis in 5.4%. In 54.1% the lesion involved the right orbit and in 5.4% bilateral involvement was found. Orbital imaging showed infiltrative lesion in 62.2%, mass lesion in 21.6%, isolated muscle thickening in 10.8%, and bone metastasis in 5.4%. All cases of HCC showed osteoclastic changes, and all cases of prostatic carcinoma were osteoblastic lesions. CONCLUSION: Orbital metastasis from HCC represented a higher incidence when compared to previous studies, probably due to the increased incidence of HCC found in the Egyptian population. Orbital metastasis can display a variety of clinical and imaging features, and a high index of suspicion is required, as 24.3% showed negative history of cancer. Dove Medical Press 2015-09-10 /pmc/articles/PMC4574802/ /pubmed/26392748 http://dx.doi.org/10.2147/OPTH.S87788 Text en © 2015 Eldesouky and Elbakary. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Eldesouky, Mohammed A
Elbakary, Molham A
Clinical and imaging characteristics of orbital metastatic lesions among Egyptian patients
title Clinical and imaging characteristics of orbital metastatic lesions among Egyptian patients
title_full Clinical and imaging characteristics of orbital metastatic lesions among Egyptian patients
title_fullStr Clinical and imaging characteristics of orbital metastatic lesions among Egyptian patients
title_full_unstemmed Clinical and imaging characteristics of orbital metastatic lesions among Egyptian patients
title_short Clinical and imaging characteristics of orbital metastatic lesions among Egyptian patients
title_sort clinical and imaging characteristics of orbital metastatic lesions among egyptian patients
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574802/
https://www.ncbi.nlm.nih.gov/pubmed/26392748
http://dx.doi.org/10.2147/OPTH.S87788
work_keys_str_mv AT eldesoukymohammeda clinicalandimagingcharacteristicsoforbitalmetastaticlesionsamongegyptianpatients
AT elbakarymolhama clinicalandimagingcharacteristicsoforbitalmetastaticlesionsamongegyptianpatients